Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program

Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…

STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Tuesday 22 September →